INmune Bio, Inc.

INMB · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$27,734$33,374$19,337$20,922
Short-Term Investments$0$0$0$0
Receivables$0$2,155$1,416$1,409
Inventory$0$0$0$0
Other Curr. Assets$2,936$505$207$331
Total Curr. Assets$30,670$36,034$20,960$22,662
Property Plant & Equip (Net)$1,064$1,080$278$307
Goodwill$0$0$0$0
Intangibles$0$0$16,514$16,514
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,624$570$49$79
Total NC Assets$2,688$1,650$16,841$16,900
Other Assets$0$0$0$0
Total Assets$33,358$37,684$37,801$39,562
Liabilities
Payables$0$7,855$7,301$6,564
Short-Term Debt$457$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$6,900$511$480$517
Total Curr. Liab.$7,357$8,586$7,927$7,221
LT Debt$623$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$623$231$201$244
Other Liabilities$0$0$0$0
Cap. Leases$1,080$451$347$384
Total Liabilities$7,980$8,817$8,128$7,465
Equity
Pref Stock$0$0$0$0
Common Stock$27$27$23$22
Retained Earnings-$203,773-$197,301-$172,843-$163,104
AOCI-$764-$763-$610-$575
Other Equity$229,888$0$0$0
Total Equity$25,378$28,867$29,673$32,097
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$33,358$37,684$37,801$39,562
Net Debt-$26,654-$33,374-$19,337-$20,922